Effects of a Dexmedetomidine on Quality of Recovery 40 and Postoperative Nausea and Vomiting in Breast Cancer Surgery
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Postoperative nausea and vomiting (PONV) is common following beast surgery. Dexmedetomidine
was reported to a reduced PONV due to opioid-sparing effect. It is not clear if
dexmedetomidine itself is useful on reducing PONV. The hypothesis of present study:
intraoperative application of single dose dexmedetomidine (0.5 mcg/kg) is is effective than
placebo for reducing of PONV and improve postoperative quality of recovery score within 48
postoperative hours.